# Comparison of 4.0 mg/kg Sugammadex at 1-2 Post Tetanic Counts (PTC) in Renal or Control Patients (19.4.328)(P05769)

> **NCT00702715** · PHASE3 · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 69 (actual)

## Conditions studied

- Anesthesia

## Interventions

- **DRUG:** sugammadex

## Key facts

- **NCT ID:** NCT00702715
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-09-24
- **Primary completion:** 2010-03-15
- **Final completion:** 2010-03-15
- **Target enrollment:** 69 (ACTUAL)
- **Last updated:** 2017-05-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00702715

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00702715, "Comparison of 4.0 mg/kg Sugammadex at 1-2 Post Tetanic Counts (PTC) in Renal or Control Patients (19.4.328)(P05769)". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT00702715. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*